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Edited by Barry HalliwellAbstract Amyloid deposits derived from the amylin peptide
accumulate within pancreatic islet b-cells in most cases of
type-2 diabetes mellitus (T2Dm). Human amylin ‘oligomers’
are toxic to these cells. Using two diﬀerent experimental tech-
niques, we found that H2O2 was generated during the aggrega-
tion of human amylin into amyloid ﬁbrils. This process was
greatly stimulated by Cu(II) ions, and human amylin was re-
tained on a copper aﬃnity column. In contrast, rodent amylin,
which is not toxic, failed to generate any H2O2 and did not inter-
act with copper. We conclude that the formation of H2O2 from
amylin could contribute to the progressive degeneration of islet
cells in T2Dm.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Type-2 diabetes mellitus (T2Dm) is an incurable disease that
is characterized by hyperglycaemia arising from defects in both
insulin action at responsive tissues and insulin secretion from
b-cells in the pancreatic islets of Langerhans. Amyloid deposits
are found in islet b-cells in up to 90% of patients with T2Dm
[1]. They are derived from a peptide hormone called amylin
[2] (or, alternatively, islet amyloid polypeptide [3]) that is made
and co-secreted along with insulin [1]. In T2Dm, the levels of
amylin are raised in parallel with the increased demand forAbbreviations: Ab, amyloid b-peptide; AD, Alzheimer’s disease; AFM,
atomic force microscopy; DETAPAC, diethylenetriaminepentaacetic
acid; DMPO, 5,5-dimethyl-1-pyrroline N-oxide; DMPO-OH, DMPO
hydroxyl radical adduct; DMSO, dimethyl sulfoxide; EM, electron
microscopy; ESR, electron spin resonance; hA, human amylin; HRP,
horseradish peroxidase; PBS, phosphate-buﬀered saline; rA, rodent
amylin; SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel
electrophoresis; T2Dm, type-2 diabetes mellitus
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doi:10.1016/j.febslet.2007.06.061insulin, and this is thought to induce concentration-dependent
amylin aggregation [1]. Islet amyloid formation is associated
with reduced b-cell mass [4] and human amylin ‘oligomers’
(small, soluble aggregates) are toxic to cultured islet cells
[5,6], suggesting that they could contribute to progressive islet
b-cell failure. Amylin oligomers can disrupt membranes [7,8]
and inﬂict oxidative damage to cells [9], but the precise molec-
ular mechanisms responsible for these eﬀects have not been
established.
The Ab peptide, which accumulates at the centre of senile
plaques in the brain in Alzheimer’s disease (AD), can generate
H2O2 directly from molecular oxygen, apparently via electron-
transfer reactions involving bound redox-active transition me-
tal ions (Fe and Cu) [10]. H2O2 is itself toxic to cells, but, if
formed in the vicinity of redox-active metal ions, such as
Fe(II), is readily converted into hydroxyl radicals, via Fenton’s
reaction. These highly reactive radicals can induce damaging
oxidation, cell toxicity and cell death.
Here, we show that the human amylin peptide also has the
ability to generate H2O2 during amyloid ﬁbril formation
in vitro, and that this process is greatly stimulated by Cu(II)
ions.2. Materials and methods
2.1. Synthetic peptides
Human amylin (amide) (hA) (Fig. 1) was purchased from American
Peptide Company, Sunnyvale, CA, USA. Its purity was 93.3% as
determined by high-performance liquid chromatography mass spectro-
scopic analysis. The equivalent rodent amylin peptide (rA) (Fig. 1) was
purchased from the same source (purity 99%).
The Ab(1–40) and Ab(1–42) peptides were synthesised on a Milligen
9050 peptide synthesiser as described in detail elsewhere [11]. The con-
trol peptides Ab(40–1) (reverse) and Ab(1–40)Met35Nle were from
Biosource International (Belgium).
2.2. Amplex Red assay
Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) is a non-ﬂuores-
cent compound that is oxidised by H2O2 in the presence of horseradish
peroxidase (HRP) to yield the highly ﬂuorescent product, resoruﬁn
[12]. Both the Ab and amylin peptides were incubated at 100 lM in
50 mM Na phosphate, 0.14 M NaCl, pH 7.4 (PBS) at 37 C for se-
lected time periods before testing for H2O2 formation. For the Amplex
Red assays, a 10 mM stock solution of Amplex Red was prepared inblished by Elsevier B.V. All rights reserved.
hA KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2
rA KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2
1 10 20 30 73
Fig. 1. Amylin peptides employed for this study. Amino acid
diﬀerences between human amylin (hA) and rodent amylin (rA) are
underlined.
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prepared in phosphate-buﬀered saline (PBS) (both stored at 20 C).
To produce the Amplex Red working solution, the stock HRP was di-
luted 1/1000 in PBS and this diluted HRP solution (100 ll) and Am-
plex Red stock solution (50 ll) were added to 4.85 ml of PBS.
Standard curves were obtained using H2O2 solutions with concentra-
tions ranging from 0.05 to 1.0 lM. For the assay, a 10 ll sample of
standard H2O2 solution, or test sample, was added to each well of a
black, ﬂat-bottomed, 384-well microtitre plate (Nunc), in triplicate,
and then 10 ll of Amplex Red working solution was added. Similar re-
sults were obtained with 50 ll samples plus 50 ll Amplex Red working
solution, in 96-well plates. Fluorescence of the resoruﬁn product was
read, after 30 min incubation at room temperature, on a Victor2
1420 plate reader, with kEx = 544 nm and kEm = 590 nm. Solutions
containing no H2O2 were used as a measure of background ﬂuores-
cence, which was subtracted from all values.
In some experiments, catalase (1000 U/ml) was added to the peptide
samples at the end of their incubation period, before they were added
to the Amplex Red working solution. In others, the metal ion chelator
diethylenetriaminepentaacetic acid (DETAPAC) (100 lM) was added
prior to incubation of the peptide solutions.
To study the eﬀects of metal ions, hA (100 lM) was incubated for
various times at 37 C in the presence of 10 lM of each of the follow-
ing:- CuCl2, ZnCl2, FeCl3, AlCl3, MgCl2; rA was incubated with
10 lM CuCl2 as a control. In these experiments, HEPES buﬀer
(10 mM N-2-hydroxyethylpiperazine-N 0-2-ethanesulfonic acid, pH
7.4) was used in all treatments (including controls) instead of PBS.
The samples were then tested using the Amplex Red method.
2.3. Electron spin resonance (ESR) spectroscopy
The hydroxyl radical was formed (via Fenton chemistry) from any
H2O2 generated during incubation of the required peptide at 100 lM
in PBS, at 37 C and detected by ESR spectroscopy, as described pre-
viously [13–15]. The method employed the reaction of this radical with
the spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) to form the
hydroxyl radical adduct (DMPO-OH), which has a uniquely character-
istic 4-line ESR spectrum with a(N) 1.50 and a(Hb) 1.46 mT [13–15].
Samples of the required peptide (50 ll), incubated both in the absence
and presence of various metal ions (2 lM), were withdrawn at selected
time-points for ESR analysis.0
0.1
0.2
0.3
0.4
0.5
0 20 40 60
Incubation time (hrs)
Aβ(1-40)
H 2
O 2
 
co
n
c.
 (μ
M
)
Aβ(1-40) + catalase 
Aβ(1-40) + DETAPAC 
Aβ(40-1)
Aβ(1-40)Met35Nle
a b
Fig. 2. Results for Ab, employing the Amplex Red method. (a) Ab(1–40)
Ab(40–1) and Ab(1–40)Met35Nle; (b) Ab(1–42) incubated with and without2.4. Atomic force microscopy
Samples selected for analysis by atomic force microscopy (AFM) at
various time points were diluted 5 times in MQ water prior to imaging.
The diluted samples (1 ll) were applied to freshly cleaved mica-covered
metal sample stubs and air dried. AFM imaging was undertaken using
a Multimode AFM with a Nanoscope IIIa controller in tapping mode
in air with Si3N4 high spring constant cantilevers (TESP, Veeco, Cam-
bridge, UK). A high-resolution scanner (E-type scanner, Veeco) was
used to allow the best possible resolution of deposits at early incuba-
tion times. Five randomly chosen areas were imaged on each sample
and the subsequent images were then carefully analyzed for ultrastruc-
tural diﬀerences.
2.5. Transmission electron microscopy
Samples of incubated peptides were selected for analysis by electron
microscopy (EM) at various time points. They were applied to Form-
var-coated nickel grids for 2 min and air dried prior to negative stain-
ing with 2% (w/v) uranyl acetate for 30 s and wicked using ﬁlter paper.
The samples were air-dried and examined on a JEOL 1010 TEM.
2.6. Immobilised metal aﬃnity chromatography
HiTrap chelating columns (Amersham Biosciences, 1 ml) were
charged with either 0.1 M Cu(II) chloride or 0.1 M Fe(III) chloride
and then washed with 5 ml of MQ water and 10 ml of 20 mM sodium
phosphate, 0.5 M NaCl, pH 8 (metal-binding buﬀer) to remove excess
metal ions. hA or rA (100 lg/ml in metal binding buﬀer) were then
loaded onto the columns. The peptides were eluted by using several
‘stepwise’ concentrations of imidazole (from 0 to 100 mM in metal
binding buﬀer). The fractions from the columns were analyzed by 4–
20% Tris–Glycine sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS–PAGE).3. Results
We used two quite independent methods in order to deter-
mine if synthetic human amylin peptide (hA), or the equiva-
lent non-amyloidogenic and non-toxic rodent amylin peptide
(rA), can generate H2O2 during incubation in vitro. The ﬁrst
method employed the dye Amplex Red [12], whereas the sec-
ond method was based on our previously published ESR spec-
troscopy technique [13–15]. We also examined the time period
during which any H2O2 was formed. The ultrastructure of the
peptide aggregates was assessed from a study of AFM and
EM images.Aβ(1-42)
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We initially carried out experiments with Ab(1–40), Ab(1–
42) and related control peptides to validate the Amplex Red
method. These peptides were incubated at 100 lM in PBS at
37 C and samples were taken at various times for H2O2 assay.
An Amplex Red signal, which increased rapidly during the
early course of aggregation, was detected from both Ab(1–
40) and Ab(1–42) (Fig. 2). Overall, these results were compat-
ible with our published ESR data showing that H2O2 is gener-
ated during the early stages of Ab aggregation [16]. Inclusion
of catalase at the end of the peptide incubation period blocked
the Amplex Red signal, as did the presence during incubation
of the metal-ion chelator DETAPAC. Ab(1–40)Met35Nle and
Ab(40–1) (reverse peptide), both of which have been shown
previously not to generate H2O2 [17], failed to produce any sig-
nal in the Amplex Red assay.
We then proceeded to measure the levels of H2O2 in simi-
larly incubated solutions of hA and rA. In the case of hA,
H2O2 formation was detected during the course of peptide
aggregation, reaching a maximum at around 72 h incubation
time, before declining to background levels at longer incuba-
tion times (Fig. 3a). In contrast no H2O2 was detected during
the incubation of rA. The rate of decay of the H2O2 self-gen-
erated from hA, and hence its stability, depends upon two fac-
tors. Firstly, direct reaction with the peptide and, secondly, on
the availability of metal ions to convert it to hydroxyl radicals.
A classic example of the diﬀerences in this rate of decay can be
found when comparing H2O2 levels generated by Ab (slow de-
cay) with those from ABri (rapid decay) [16].
Freshly dissolved hA peptide showed no clear structures
(Fig. 4a) but analysis of EM and AFM images obtained during
the early stages of H2O2 formation (3–6 h) revealed the pres-
ence of numerous short ‘protoﬁbrils’ (Fig. 4b and c) whereas
samples examined after prolonged incubation periods (24–
72 h) revealed the presence of longer amyloid ﬁbrils
(Fig. 4d). The peroxide was, therefore, generated during amy-
loid ﬁbril formation. The AFM images of the protoﬁbrils
formed from hA (Fig. 4c) were similar in appearance to those
observed with Ab [16]. When hA was incubated in the presence0.
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Fig. 3. Results for amylin, employing the Amplex Red method. (a) hA, with a
hA and rA. In addition to those shown, Al(III) and Mn(II) had no signiﬁcaof various metal ions, only Cu(II) stimulated the formation of
H2O2 to any great extent (Fig. 3b). In the presence of Cu(II),
the Amplex Red signal from hA again reached a peak at
around 72 h incubation time, but there was a 6-fold increase
in H2O2 levels compared with those obtained from hA alone.
The ultrastructural appearance of the hA aggregates formed
during incubation, or the aggregation time, did not appear
to be markedly changed by the presence of Cu(II) ions
(Fig. 4e and f). It should be noted that no distinct ﬁbrils were
observed with rA incubated with or without Cu(II) ions.
In all of these experiments, any positive signal from hA was
always blocked by the addition of catalase at the end of the
peptide incubation period (conﬁrming the detection of H2O2)
or by the inclusion of DETAPAC during peptide incubation
(suggesting that metal ions are involved) (Fig. 3a). The pres-
ence of Cu(II) ions during the incubation of rA failed to stim-
ulate the formation of H2O2 (Fig. 3b).
3.2. ESR measurements
For the ESR method, hA was incubated (as before) in the
presence or absence of various metal ions, and any H2O2
formed was detected by its conversion into hydroxyl radicals,
which were trapped with DMPO [13–15]. A weak 4-line spec-
trum corresponding to the hydroxyl radical adduct was often
observed without added metal ions, but this was sometimes ab-
sent altogether (Fig. 5a). However, the intensity of this spec-
trum was greatly enhanced when hA was co-incubated with
Cu(II) ions (Fig. 5b). All of the ESR spectra obtained from
hA could be blocked with catalase (Fig. 5c) or DETAPAC
(Fig. 5d) and no spectra were observed under any conditions
from rA (Fig. 5e).
3.3. Copper ion binding to hA
hA was retained on a HiTrap metal-chelating column
charged with Cu(II) ions and could be subsequently eluted
with 25 mM (but not 10 mM) imidazole (Fig. 6a). This peptide
failed to bind to a similar column charged with Fe(III) ions
(Fig. 6b). Furthermore, rA did not bind to either of these
metal-loaded Hitrap columns (Fig. 6c).Incubation time (hrs)
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hA + Fe(III) 
hA + Zn(II)
hA
rA + Cu(II)
hA + Cu(II)
hA + Fe(III) 
hA + Zn(II)
hA
rA + Cu(II)
0 40 80 120 160
4
8
2
6
0
nd without catalase or DETAPAC; (b) eﬀects of metal ions (10 lM) on
nt eﬀect on the Amplex Red signal from hA.
Fig. 4. Ultrastructural appearance of hA aggregates. (a) EM image at zero incubation time; (b) EM image of ‘protoﬁbrils’ at 6 h incubation; (c)
AFM image of ‘protoﬁbrils’ at 6 h incubation; (d) EM image of fully-formed amyloid ﬁbrils at 72 h; (e) AFM image at 3 h incubation, in the presence
of Cu(II); (f) EM image at 72 h incubation, in the presence of Cu(II).
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Fig. 5. ESR spectra recorded from amylin peptides. (a) hA; (b) is (a)
incubated in the presence of Cu(II) (2 lM); (c) is (b) incubated in the
presence of catalase; (d) is (b) incubated in the presence of DETAPAC;
(e) rA incubated in the presence of Cu(II) (2 lM). A control
experiment containing no peptide gave spectra similar to those shown
in (a), (c), (d) and (e).
Fig. 6. Elution of amylin from metal-loaded HiTrap columns. (a) hA
binds to Cu(II) and is eluted with 25 mM imidazole: C = hA control;
A,B = 0 mM imidazole; C,D = 10 mM imidazole; E,F = 25 mM imid-
azole; G,H = 50 mM imidazole; I,J = 100 mM imidazole. (b) hA fails
to bind to Fe(III) and is eluted with the ﬁrst wash: lanes as before; (c)
rA fails to bind to Cu(II): lanes as before.
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Although it has been established previously that exposure to
the hA peptide increases H2O2 levels in cultured cells [18], our
results, employing two completely independent techniques
(i.e., Amplex Red and ESR spectroscopy), demonstrate, for
the ﬁrst time, that H2O2 is generated directly during the aggre-
gation of hA in vitro, and also that the formation of H2O2 inthis way is selectively stimulated by Cu(II) ions. The accumu-
lation of H2O2 was conﬁrmed by the experiments with cata-
lase, which blocked both of the Amplex Red and ESR
signals. Similar experiments with DETAPAC suggest the
involvement of metal ions, even when these are not added
externally to the peptide.
The demonstration of an interaction between hA and the
copper-loaded HiTrap columns suggests a mechanism for the
generation of hydrogen peroxide involving the binding of
Cu(II) ions to hA. This would potentially result in the forma-
tion of a redox-active complex. The donation of electrons from
the peptide to Cu(II) ions would result in the formation of a
Cu(I)-peptide complex, which could also be formed by the di-
rect binding of the peptide to Cu(I) ions. The Cu(I)-complex
could stimulate the formation of H2O2 from O2 and result in
A. Masad et al. / FEBS Letters 581 (2007) 3489–3493 3493a consequent return to the Cu(II) oxidation state. Subsequent
cycling of this redox system could occur, resulting in the gen-
eration of hydroxyl radicals from H2O2 via Fenton chemistry.
The formation of H2O2 from hA by this type of mechanism
could explain the well-established toxicity of this peptide to-
wards cultured islet cells. This would be in accord with previ-
ous reports that the cytotoxicity induced by hA involves
oxidative damage [9] and can be reduced by anti-oxidants
[19]. The ready formation of hydroxyl radicals from H2O2 in
the presence of redox-active transition metal ions could also
contribute towards in vivo damage to the pancreas in T2Dm,
for which there is extensive evidence for the involvement of
reactive oxygen species [1].
Our results also add weight to the emerging hypothesis that
oxidative damage during early oligomer formation could rep-
resent a common mechanism of toxicity for many amyloido-
genic proteins and peptides [8,13–17,20]. This hypothesis is
further supported by the fact that rA, which is not toxic to cells
[21,22], failed to generate any H2O2 in our experiments, pre-
sumably due to its inability to aggregate and/or to interact with
copper ions.
A possible role for copper ions in T2Dm has already been
implied by the ﬁnding that the level of copper is signiﬁcantly
higher (while those of zinc and magnesium are lower) in serum
from diabetic patients than controls [23]. This suggest that
copper could play an important role in the pathogenesis of
T2Dm, possibly including the facilitation of H2O2 generation
from amylin, and, ultimately in the degeneration and death
of pancreatic islet cells. Our data provide a new rationale
and added impetus for the clinical use of copper chelators in
T2Dm [24] as well as opening up additional avenues of re-
search into the etiology, pathogenesis and treatment of this
disease.
Acknowledgements: We thank The Ford Foundation (USA) for an
International Postgraduate Research Studentship (to A.M.) and The
Wellcome Trust for a Project Grant (GR065764AIA).References
[1] Ho¨ppener, J.W. and Lips, C.J.M. (2006) Role of islet amyloid in
type 2 diabetes mellitus. Int. J. Biochem. Cell Biol. 38, 726–736.
[2] Cooper, G.J.S., Willis, A.C., Clark, A., Turner, R.C., Sim, R.B.
and Reid, K.B.M. (1987) Puriﬁcation and characterization of a
peptide from amyloid-rich pancreases of type 2 diabetic patients.
Proc. Natl. Acad. Sci. USA 84, 8628–8632.
[3] Westermark, P., Wernstedt, C., Wilander, E., Hayden, D.W.,
O’Brien, T.D. and Johnson, K.H. (1987) Amyloid ﬁbrils in human
insulinoma and islets of langerhans of the diabetic cat are derived
from a neuropeptide-like protein also present in normal islets.
Proc. Natl. Acad. Sci. USA 84, 3881–3885.
[4] De Koning, E.J., Bodkin, N.L., Hansen, B.C. and Clark, A.
(1993) Diabetes mellitus in Macaca mulatto monkeys is charac-
terised by islet amyloidosis and reduction in beta cell population.
Diabetologia 36, 378–384.
[5] Konarkowska, B., Aitken, J.F., Kistler, J., Zhang, S. and Cooper,
G.J. (2006) The aggregation potential of human amylin deter-
mines its cytotoxicity towards islet beta-cells. FEBS J. 273, 3614–
3624.
[6] Ritzel, R.A., Meier, J.J., Lin, C.-Y., Veldhuis, J.D. and Butler,
P.C. (2007) Human islet amyloid polypeptide oligomers disrupt
cell coupling, induce apoptosis, and impair insulin secretion in
isolated human islets. Diabetes 56, 65–71.
[7] Janson, J., Ashley, R.H., Harrison, D., McIntyre, S. and Butler,
P.C. (1999) The mechanism of islet amyloid polypeptide toxicity ismembrane disruption by intermediate-sized toxic amyloid parti-
cles. Diabetes 48, 491–498.
[8] Kayed, R., Sokolov, Y., Edmonds, B., McIntyre, T.M., Milton,
S.C., Hall, J.E. and Glabe, C.G. (2004) Permeabilization of lipid
bilayers is a common conﬁrmation-dependent activity of soluble
oligomers in protein folding diseases. J. Biol. Chem. 279, 46363–
46366.
[9] Janciauskiene, S. and Ahre´n, B. (2000) Fibrillar islet amyloid
polypeptide diﬀerentially aﬀects oxidative mechanisms and lipo-
protein uptake in correlation with cytoxicity in two insulin-
producing cell lines. Biochem. Biophys. Res. Commun. 267, 619–
625.
[10] Huang, X.D., Atwood, C.S., Hartshorn, M.A., Multhaup, G.,
Goldstein, L.E., Scarpa, R.C., Cuajungco, M.P., Gray, D.N.,
Lim, J., Moir, R.D., Tanzi, R.E. and Bush, A.I. (1999) The A beta
peptide of Alzheimer’s disease directly produces hydrogen perox-
ide through metal ion reduction. Biochemistry 38, 7609–7616.
[11] El-Agnaf, O.M.A., Goodwin, H., Sheridan, J.M., Frears, E.R.
and Austen, B.M. (2000) Improved solid-phase syntheses of
amyloid proteins associated with neurodegenerative diseases.
Protein Peptide Lett. 7, 1–8.
[12] Zhou, M., Diwu, Z., Panchuk-Voloshina, N. and Haugland, R.P.
(1997) A stable nonﬂuorescent derivative of resoruﬁn for the
ﬂuorometric determination of trace hydrogen peroxide: applica-
tions in detecting the activity of phagocyte NADPH oxidase and
other oxidases. Anal. Biochem. 253, 162–168.
[13] Turnbull, S., Tabner, B.J., El-Agnaf, O.M.A., Moore, S., Davies,
Y. and Allsop, D. (2001) a-Synuclein implicated in Parkinson’s
disease catalyses the formation of hydrogen peroxide in vitro.
Free Radical Biol. Med. 30, 1163–1170.
[14] Turnbull, S., Tabner, B.J., Brown, D.R. and Allsop, D. (2003)
Generation of hydrogen peroxide from mutant forms of the prion
protein fragment PrP121-231. Biochemistry 42, 7675–7681.
[15] Turnbull, S., Tabner, B.J., Brown, D.R. and Allsop, D. (2003)
Copper-dependent generation of hydrogen peroxide from the
toxic prion protein fragment PrP106–126. Neurosci. Lett. 336,
159–162.
[16] Tabner, B.J., El-Agnaf, O.M.A., Turnbull, S., German, M.J.,
Paleologou, K.E., Hayashi, Y., Cooper, L.J., Fullwood, N.J. and
Allsop, D. (2005) Hydrogen peroxide is generated during the very
early stages of aggregation of the amyloid peptides implicated in
Alzheimer’s disease and familial British dementia. J. Biol. Chem.
280, 35789–35792.
[17] Turnbull, B.J., Tabner, S., Fullwood, N.J., German, M. and
Allsop, D. (2005) The production of hydrogen peroxide during
early-stage protein aggregation: a common pathological mecha-
nism in diﬀerent neurodegenerative diseases? Biochem. Soc.
Trans. 33, 548–550.
[18] Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R.,
Sagara, Y. and Kimura, H. (1995) Amyloid peptides are toxic via
a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92,
1989–1993.
[19] Konarkowska, B., Aitken, J.F., Kistler, J., Zhang, S. and Cooper,
G.J. (2005) Thiol reducing compounds prevent human amylin-
evolved cytotoxicity. FEBS J. 272, 4949–4959.
[20] Tabner, B.J., Turnbull, S., El-Agnaf, O.M.A. and Allsop, D.
(2002) Formation of hydrogen peroxide and hydroxyl radicals
from Ab and a-synuclein as a possible mechanism of cell death in
Alzheimer’s disease and Parkinson’s disease. Free Radical Biol.
Med. 32, 1076–1083.
[21] Lorenzo, A., Razzaboni, B., Weir, G.C. and Yankner, B.A. (1994)
Pancreatic islet cell toxicity of amylin associated with type-2
diabetes mellitus. Nature 368, 756–760.
[22] Hiddinga, H.J. and Eberhardt, N.L. (1999) Intracellular amylo-
idogenesis by human islet amyloid polypeptide induces apoptosis
in COS-1 cells. Am. J. Pathol. 154, 1077–1088.
[23] Isbir, T., Tamer, L., Taylor, A. and Isbir, M. (1994) Zinc, copper
and magnesium status in insulin-dependent diabetes. Diabetes
Res. 26, 41–45.
[24] Lu, J., Chan, Y.K., Gamble, G.D., Poppitt, S.D., Othman, A.A.
and Cooper, G.T. (2007) Triethylenetetramine and metabolites:
levels in relation to copper and zinc excretion in urine of healthy
volunteers and type 2 diabetic patients. Drug Metab. Dispos. 35,
221–227.
